| Page 2 of 3 < > |
AUTOMOTIVE
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
Production is scheduled to begin in 2011 for a capacity of up to 160,000 vehicles, the French carmaker said.
japan
Hello Kitty Named Tourism Ambassador
Japan's tourism ministry named Hello Kitty as its choice to represent the country in China and Hong Kong, where the toy character is wildly popular among children and young women. Officials hope tapping into that fan base will entice tourists to visit Japan and bring the country closer to its goal of attracting 10 million overseas visitors every year. Foreign tourism hit a record high of 8.35 million visitors last year.
Arrivals from China and Hong Kong accounted for 16.5 percent of them.
INVESTING
Buffett Scouts Europe For Acquisition Targets
Warren E. Buffett, whose business and investment acumen has made him one of the world's wealthiest men, has embarked on a European tour to look for possible acquisitions for his firm Berkshire Hathaway.
Starting in Frankfurt, continental Europe's financial hub, the chairman and chief executive of Berkshire said he wanted to put his company "on the radar screens" of family-owned German businesses should they ever consider selling themselves. Buffett, 77, said his trip to seek out opportunities among Europe's biggest family-owned companies would include stops in Switzerland, Spain and Italy.
pharmaceutical
Glaxo Gets E.U. Approval For Bird Flu Vaccine
GlaxoSmithKline said it received permission from European regulators to market a human bird-flu vaccine, the first pharmaceutical to receive a license for pre-pandemic use in all 27-member European Union states.
Glaxo, which has spent some $2 billion developing the vaccine that targets the H5N1 virus, already has orders for 8 million doses from Switzerland, enough to cover that country's entire population, and an order for 27.5 million doses from the U.S. Department of Health and Human Services.
Experts think H5N1, an influenza virus subtype that has killed at least 241 people worldwide since 2003, is the most likely candidate to mutate into a pandemic virus.
Emmanuel Hanon, vice president of the Influenza Vaccine Franchise at Glaxo, said Finland and several other European countries had also placed orders.
